日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The role of radiomics in predicting the response to neoadjuvant chemotherapy for breast cancer

放射组学在预测乳腺癌新辅助化疗疗效中的作用

Chen, Yilin; Qin, Ye; Yang, Man; Li, Wei; Cheng, Minyi; Huang, Yuhong; Zhu, Teng; Wang, Kun

Multimodal nomogram for predicting axillary pathological complete response after neoadjuvant therapy in clinically node-positive breast cancer

用于预测临床淋巴结阳性乳腺癌新辅助治疗后腋窝病理完全缓解的多模态列线图

Cheng, Minyi; Li, Jieqing; Lin, Yingyi; Zou, Jiachen; Wang, Dongqing; Wu, Cangui

Intratumoral microbiota predicts the response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer

肿瘤内微生物群可预测三阴性乳腺癌对新辅助化疗免疫疗法的反应

Chen, Yilin; Yang, Lu; Huang, Yuhong; Zhu, Teng; Zhang, Liulu; Cheng, Minyi; Wu, Cangui; Li, Peiyong; Liang, Minting; Zhang, Xiaoqi; Peng, Hao; Wang, Kun

MRI-based artificial intelligence models for post-neoadjuvant surgery personalization in breast cancer: a narrative review of evidence from Western Pacific

基于磁共振成像的人工智能模型在乳腺癌新辅助手术后个体化治疗中的应用:来自西太平洋地区的证据叙述性综述

Lin, Yingyi; Cheng, Minyi; Wu, Cangui; Huang, Yuhong; Zhu, Teng; Li, Jieqing; Gao, Hongfei; Wang, Kun

Intratumoral microbiota-aided fusion radiomics model for predicting tumor response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer

肿瘤内微生物群辅助融合放射组学模型预测三阴性乳腺癌对新辅助化疗免疫疗法的肿瘤反应

Chen, Yilin; Huang, Yuhong; Li, Wei; Zhu, Teng; Cheng, Minyi; Wu, Cangui; Zhang, Liulu; Peng, Hao; Wang, Kun

Neoadjuvant Chemotherapy and Neoadjuvant Chemotherapy With Immunotherapy Result in Different Tumor Shrinkage Patterns in Triple-Negative Breast Cancer

新辅助化疗和新辅助化疗联合免疫疗法在三阴性乳腺癌中导致不同的肿瘤缩小模式

Zou, Jiachen; Zhang, Liulu; Chen, Yuanqi; Lin, Yingyi; Cheng, Minyi; Zheng, Xingxing; Zhuang, Xiaosheng; Wang, Kun

Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study

基于纵向磁共振成像融合的新型模型预测接受新辅助化疗的乳腺癌患者的病理完全缓解:一项多中心回顾性研究

Huang, YuHong; Zhu, Teng; Zhang, XiaoLing; Li, Wei; Zheng, XingXing; Cheng, MinYi; Ji, Fei; Zhang, LiuLu; Yang, CiQiu; Wu, ZhiYong; Ye, GuoLin; Lin, Ying; Wang, Kun

Low-dose apatinib combined with neoadjuvant chemotherapy in the treatment of early-stage triple-negative breast cancer (LANCET): a single-center, single-arm, phase II trial

低剂量阿帕替尼联合新辅助化疗治疗早期三阴性乳腺癌(LANCET):一项单中心、单臂 II 期试验

Yang, Ciqiu; Zhang, Junsheng; Zhang, Yi; Ji, Fei; Chen, Yitian; Zhu, Teng; Zhang, Liulu; Gao, Hongfei; Yang, Mei; Li, Jieqing; Cheng, Minyi; Wang, Kun

DAGM: A novel modelling framework to assess the risk of HER2-negative breast cancer based on germline rare coding mutations.

DAGM:一种基于种系罕见编码突变评估 HER2 阴性乳腺癌风险的新型建模框架

Yang Mei, Fan Yanhui, Wu Zhi-Yong, Gu Jin, Feng Zhendong, Zhang Qiangzu, Han Shunhua, Zhang Zhonghai, Li Xu, Hsueh Yi-Ching, Ni Yanxiang, Li Xiaoling, Li Jieqing, Hu Meixia, Li Weiping, Gao Hongfei, Yang Ciqiu, Zhang Chunming, Zhang Liulu, Zhu Teng, Cheng Minyi, Ji Fei, Xu Juntao, Cui Hening, Tan Guangming, Zhang Michael Q, Liang Changhong, Liu Zaiyi, Song You-Qiang, Niu Gang, Wang Kun

Visualization positioning-guided biopsy of suspicious breast microcalcifications: a retrospective cohort study

可视化定位引导下可疑乳腺微钙化活检:一项回顾性队列研究

Zhang, Liulu; Cheng, Minyi; Chen, Yuanqi; Zhuang, Xiaosheng; Yang, Ciqiu; Ji, Fei; Gao, Hongfei; Yang, Mei; Zhu, Teng; Li, Jieqing; Wang, Kun